How Saudi Arabia is developing as a Middle East hub for clinical trials

Saudi Arabia is emerging as a major growth market for clinical trials in the Middle East, underpinned by strong funding and rapidly developing infrastructure. Saudi Arabia is emerging as a major growth market for clinical trials in the Middle East, underpinned by strong funding and rapidly developing infrastructure. Vision 2030 reforms and specialised clinical trial logistics are coming together to enable complex, multicentre studies across the Kingdom. Saudi Arabia is primed for growth in clinical trials. Credit: via Shutterstock. Saudi Arabia is primed to emerge as the Middle East’s key hub for clinical trials, driven by both sustained state investment…

Source: Pharmaceutical Technology